Allogeneic carrier-specific enhancement of hapten-specific secondary B-cell responses
- PMID: 1086883
- PMCID: PMC2190464
- DOI: 10.1084/jem.144.5.1254
Allogeneic carrier-specific enhancement of hapten-specific secondary B-cell responses
Abstract
We have analyzed the capacity of carrier-specific T cells to enhance the immune response of hapten-specific secondary B cells which do not share genes in the H-2 complex with the T cells. For this analysis we have used the in vitro splenic focus technique which allows assessment of monoclonal responses of B cells isolated in splenic fragment cultures of irradiated reconstituted carrier primed mice. A previous report from this laboratory demonstrated that syngeny in the I region of the H-2 complex was necessary between collaborating hapten-specific primary (nonimmune) B cells and carrier-specific T cells for responses yielding IgG1 but not IgM antibody. These findings lead up to postulate that the expression of I-region gene products on the surface of primary B cells and I-region syngeny with collaborating carrier-specific T cells were essential elements in the triggering events leading to IgG1 synthesis by primary B cells. The results presented in the present report indicate that, unlike primary B cells, the majority of secondary B cells can be stimulated to produce IgG1 antibody in carrier-primed allogeneic recipients. Although the enhancement of secondary IgG1 responses is slightly greater with syngeneic T cells, the allogeneic collaborative interaction requires both carrier priming of recipient mice and stimulation with the homologous hapten-carrier complex and thus appears to be specific. These findings clearly discriminate secondary from primary B cells and indicate that the mechanism of stimulation of secondary B cells to yield IgG1-producing clones differs fundamentally from the stimulation of primary B cells in that the requisite for I-region syngeny is obviated.
Similar articles
-
The allogeneic bisection of carrier-specific enhancement of monoclonal B-cell responses.J Exp Med. 1975 Nov 1;142(5):1165-79. doi: 10.1084/jem.142.5.1165. J Exp Med. 1975. PMID: 811749 Free PMC article.
-
The immunological properties of haptens coupled to thymus-independent carrier molecules. IV. The IgG response to dinitrophenylated Ficoll.Eur J Immunol. 1976 Jun;6(6):429-33. doi: 10.1002/eji.1830060610. Eur J Immunol. 1976. PMID: 1086786
-
Cell co-operation and hapten--carrier complexes.Immunology. 1975 Oct;29(4):675-85. Immunology. 1975. PMID: 52618 Free PMC article.
-
Functional specificity of thymus- dependent lymphocytes.Science. 1977 Mar 25;195(4284):1293-300. doi: 10.1126/science.320663. Science. 1977. PMID: 320663 Review.
-
Immune responses to hapten conjugates in vitro.Q Rev Biophys. 1975 Nov;8(4):507-22. doi: 10.1017/s0033583500001979. Q Rev Biophys. 1975. PMID: 769043 Review. No abstract available.
Cited by
-
Antigen-binding mutants of mouse myeloma cells.Proc Natl Acad Sci U S A. 1977 Dec;74(12):5687-91. doi: 10.1073/pnas.74.12.5687. Proc Natl Acad Sci U S A. 1977. PMID: 271995 Free PMC article.
-
Expression of an idiotype (Id-460) during in vivo anti-dinitrophenyl antibody responses. I. Mapping of genes for Id-460 expression to the variable region of immunoglobulin heavy-chain locus and to the variable region of immunoglobulin kappa-light-chain locus.J Exp Med. 1980 Sep 1;152(3):720-9. doi: 10.1084/jem.152.3.720. J Exp Med. 1980. PMID: 6774049 Free PMC article.
-
Mutant monoclonal antibodies with alterations in biological functions.J Exp Med. 1982 Oct 1;156(4):1131-48. doi: 10.1084/jem.156.4.1131. J Exp Med. 1982. PMID: 6818317 Free PMC article.
-
Balb/c T cells have the potential to recognize the TEPC 15 prototype antibody and its somatic variants.J Exp Med. 1981 Oct 1;154(4):1178-87. doi: 10.1084/jem.154.4.1178. J Exp Med. 1981. PMID: 6974760 Free PMC article.
-
The collaborative phenotype of secondary B cells is determined by T lymphocytes during in vivo immunization.J Exp Med. 1982 Feb 1;155(2):574-86. doi: 10.1084/jem.155.2.574. J Exp Med. 1982. PMID: 6173458 Free PMC article.